IL96388A

Preparation of(-+)-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole 1,7-dicarboxylates and preparation of 5-aroyl-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole-1-carboxylic acid derivatives thereof

Abstract

This record has no abstract on file.

IL96388A, drawing sheet 1
Sheet 1 of 17

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

4 claims: 1 independent, 3 dependent

  1. 1
    A process for producing a diester of formula CLAIMS :XII, (XII) in which each R is independently hydrogen, lower alkyl or cycloalkyl, which comprises cyclizing a compound of formula XVI, (XVI) in which R is as defined above;and X is halogen, with a lithium hindered amine in an aprotic polar solvent. .
  2. 2
    The process of Claim 1 wherein each R is CH3 and X is Br or Cl.
  3. 3
    The process of Claim 1 which further comprises saponification of the thus-formed diester (xil) to the corresponding diacid (xil, R = H).
  4. 4
    The process of Claim 3 which further comprises (a) esterifying a compound of formula (XII) in which Doth R groups are hydrogen to form a compound of formula (XVIII) in which the R group in position 1 is 4S 4#׳ alkyl; (р) decarboxylating a compound of formula (XVIII) to form a compound of formula (XLX) ; and (с) aroylation of a compound of formula (XIX) with an amide or morpholide to form a compound of formula (I) or (IA). 6 7 (I) or (IA) wnerein Ar is substituted or unsubstituted phenyl, 2- or 3-furyl, 2- or 3-thienyl, or 2- or 3-pyrry1 and which, if 20 substituted, can have one or more lower alkyl, lower alkoxy, or halo groups in any available position on the ring, and R is hydrogen (formula I) or alkyl of-1 to 12 carbon atoms (formula IA). 25 5. The process of Claim 4. which further comprises one or more of the steps:(a) converting a compound of formula (I) to a pharmaceutically acceptable salt of a compound of formula (I) ;or , 30 (t>) converting a salt of a compound of formula (I) to the corresponding free compound of formula (I);or (c) esterifying a compound of formula (I);or (d) converting an ester of formula (IA) to the corresponding free compound of formula (I). -w- > The process of Claims 4 or 5, wherein the compound formed is 5-benzoyl-l,2-dihydro-3H-pyrrolo[1,2- a]pyrrole-l-carboxylic acid or a pharmaceutically acceptable salt or ester thereof. The process of Claims 4 or 5, wherein the compound formed is 5-2־anisoyl-l,2-dihydro-3H-pyrrolo[l,2- a]-pyrrole-l-carboxylic acid or a pharmaceutically acceptable salt or ester thereof.